Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Last week, ratings agency Standard & Poor’s Ratings Services (S&P) downgraded the long-term issuer credit rating (ICR) of CME Group Inc. (CME - Analyst Report) to “AA-” from “AA”. Additionally, S&P gave a “Negative” outlook to the rating, thereby indicating the possibility of a further downgrade in the near future.

The move came on the back of S&P’s concern over the $100 million fund announced by CME to protect the interest of farmers and ranchers affected by the crash of MF Global. Under the Family Farmer and Rancher Protection Fund, expected to be in effect by March 1, 2012, farmers and ranchers using CME Group products will be eligible for up to $25,000 per account in case of losses resulting from the future insolvency of a clearing member or other market participant.

Last year, the exchange had also announced a guarantee of $250 million to the estate trustees of MF Global, following the collapse of the commodities firm, in order to make the process of returning customers’ funds more rapid.

CME, as the regulator of MF Global, announced the guarantees to protect consumers’ interest as well as boost its sagging trading volume subsequent to the company’s collapse. Nevertheless, S&P views the move unfavorably.

While the ratings agency concedes the financial risk posed by the guarantees is minimal and can be covered by CME from its free operating cash flow within six months, it believes that the move will raise customers’ expectations regarding future guarantees.

S&P is also apprehensive about CME’s increasing exposure to credit default swaps, as the exchange has limited experience in managing the product. The ratings agency opines that some of the counterparty risk of the off-exchange businesses gets transferred to the clearing house. Nevertheless, CME’s ICR is still strong, with only 21 companies in the S&P 500 having equivalent or better ratings.

CME’s main competitors are CBOE Holdings, Inc. (CBOE - Analyst Report) and Nasdaq OMX Group Inc. (NDAQ - Analyst Report). The shares of CME carry a Zacks #3 Rank, which translates into a short-term ‘Hold’ rating. However, considering the fundamentals, we maintain our long-term ‘Neutral’ recommendation on the stock.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%